Global Antifungal Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Antifungal Revenue
• 1.4 Market by Type
  • 1.4.1 Global Antifungal Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oral Administration
  • 1.4.3 External Use
• 1.5 Market by Application
  • 1.5.1 Global Antifungal Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Drug Stores
  • 1.5.5 Online Sales
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Antifungal Market Perspective (2015-2026)
• 2.2 Global Antifungal Growth Trends by Regions
  • 2.2.1 Antifungal Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Antifungal Historic Market Share by Regions (2015-2020)
  • 2.2.3 Antifungal Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Antifungal Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Antifungal Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Antifungal Players by Market Size
  • 3.1.1 Global Top Antifungal Players by Revenue (2015-2020)
  • 3.1.2 Global Antifungal Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Antifungal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Antifungal Market Concentration Ratio
  • 3.2.1 Global Antifungal Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Antifungal Revenue in 2019
• 3.3 Antifungal Key Players Head office and Area Served
• 3.4 Key Players Antifungal Product Solution and Service
• 3.5 Date of Enter into Antifungal Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Antifungal Historic Market Size by Type (2015-2020)
• 4.2 Global Antifungal Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Antifungal Market Size by Application (2015-2020)
• 5.2 Global Antifungal Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Antifungal Market Size (2015-2020)
• 6.2 Antifungal Key Players in North America (2019-2020)
• 6.3 North America Antifungal Market Size by Type (2015-2020)
• 6.4 North America Antifungal Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Antifungal Market Size (2015-2020)
• 7.2 Antifungal Key Players in Europe (2019-2020)
• 7.3 Europe Antifungal Market Size by Type (2015-2020)
• 7.4 Europe Antifungal Market Size by Application (2015-2020)

8 China

• 8.1 China Antifungal Market Size (2015-2020)
• 8.2 Antifungal Key Players in China (2019-2020)
• 8.3 China Antifungal Market Size by Type (2015-2020)
• 8.4 China Antifungal Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Antifungal Market Size (2015-2020)
• 9.2 Antifungal Key Players in Japan (2019-2020)
• 9.3 Japan Antifungal Market Size by Type (2015-2020)
• 9.4 Japan Antifungal Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Antifungal Market Size (2015-2020)
• 10.2 Antifungal Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Antifungal Market Size by Type (2015-2020)
• 10.4 Southeast Asia Antifungal Market Size by Application (2015-2020)

11 India

• 11.1 India Antifungal Market Size (2015-2020)
• 11.2 Antifungal Key Players in India (2019-2020)
• 11.3 India Antifungal Market Size by Type (2015-2020)
• 11.4 India Antifungal Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Antifungal Market Size (2015-2020)
• 12.2 Antifungal Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Antifungal Market Size by Type (2015-2020)
• 12.4 Central & South America Antifungal Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Novartis (Switzerland)
  • 13.1.1 Novartis (Switzerland) Company Details
  • 13.1.2 Novartis (Switzerland) Business Overview
  • 13.1.3 Novartis (Switzerland) Antifungal Introduction
  • 13.1.4 Novartis (Switzerland) Revenue in Antifungal Business (2015-2020))
  • 13.1.5 Novartis (Switzerland) Recent Development
• 13.2 Pfizer (U.S)
  • 13.2.1 Pfizer (U.S) Company Details
  • 13.2.2 Pfizer (U.S) Business Overview
  • 13.2.3 Pfizer (U.S) Antifungal Introduction
  • 13.2.4 Pfizer (U.S) Revenue in Antifungal Business (2015-2020)
  • 13.2.5 Pfizer (U.S) Recent Development
• 13.3 Sanofi (France)
  • 13.3.1 Sanofi (France) Company Details
  • 13.3.2 Sanofi (France) Business Overview
  • 13.3.3 Sanofi (France) Antifungal Introduction
  • 13.3.4 Sanofi (France) Revenue in Antifungal Business (2015-2020)
  • 13.3.5 Sanofi (France) Recent Development
• 13.4 Merck (U.S)
  • 13.4.1 Merck (U.S) Company Details
  • 13.4.2 Merck (U.S) Business Overview
  • 13.4.3 Merck (U.S) Antifungal Introduction
  • 13.4.4 Merck (U.S) Revenue in Antifungal Business (2015-2020)
  • 13.4.5 Merck (U.S) Recent Development
• 13.5 Astellas (Japan)
  • 13.5.1 Astellas (Japan) Company Details
  • 13.5.2 Astellas (Japan) Business Overview
  • 13.5.3 Astellas (Japan) Antifungal Introduction
  • 13.5.4 Astellas (Japan) Revenue in Antifungal Business (2015-2020)
  • 13.5.5 Astellas (Japan) Recent Development
• 13.6 Bayer (Germany)
  • 13.6.1 Bayer (Germany) Company Details
  • 13.6.2 Bayer (Germany) Business Overview
  • 13.6.3 Bayer (Germany) Antifungal Introduction
  • 13.6.4 Bayer (Germany) Revenue in Antifungal Business (2015-2020)
  • 13.6.5 Bayer (Germany) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer